Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SBUX vs MRNA✓SelectedUSD · MRNASBUX vs MRNA performance historyLatest closeAs of-1.28%11/20
Stock and ETF performance explorer

SBUX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.7%
MRNA return
+153.9%
Excess return
-147.2%
Maximum drawdown
-31.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.3%-2.2%+0.9%-1.2%
7D-3.1%-12.7%+9.6%-2.9%
30D+4.7%-20.7%+25.4%+5.1%
3M-0.2%+46.3%-46.5%-1.2%
6M-2.0%+305.2%-307.3%-8.7%
YTD+25.4%+561.2%-535.8%+10.8%
1Y+27.8%+772.1%-744.3%+9.9%
3Y+6.7%+147.0%-140.3%-3.5%
All+6.7%+153.9%-147.2%-3.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling